SCHEMBL12419082

SCHEMBL12419082

[3H]SONC1CC(=O)N(CCC(=O)NCCNC(=O)C(CCCCNC(=O)OCC)NC(=O)OCC)C1=O

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SIRT2 Q8IXJ6 8/20 0.36
▸ SIRT1 Q96EB6 5/20 0.35
▸ HDAC4 P56524 2/20 0.35
▸ EP300 Q09472 1/20 0.35
▸ MEF2D Q14814 1/20 0.35
▸ SIRT3 Q9NTG7 3/20 0.34
▸ ACE P12821 1/20 0.34
▸ TPSAB1 Q15661 2/20 0.33
▸ KLK7 P49862 2/20 0.33
▸ KLK5 Q9Y337 2/20 0.33
▸ CAPN1 P07384 1/20 0.32
▸ CAPN2 P17655 1/20 0.32
▸ HDAC3 O15379 1/20 0.32
▸ HDAC1 Q13547 1/20 0.32
▸ HDAC7 Q8WUI4 1/20 0.32
▸ HDAC2 Q92769 1/20 0.32
▸ HDAC10 Q969S8 1/20 0.32
▸ HDAC11 Q96DB2 1/20 0.32
▸ HDAC8 Q9BY41 1/20 0.32
▸ HDAC6 Q9UBN7 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL277682 0.89 SIRT2 (0.39) SIRT2SIRT1HDAC4EP300MEF2D
SCHEMBL13311607 0.89 SIRT2 (0.39) SIRT2SIRT1HDAC4EP300MEF2D
SCHEMBL12419151 0.86 SIRT2 (0.38) SIRT2SIRT1HDAC4EP300MEF2D
SCHEMBL9910894 0.85 SIRT2 (0.40) SIRT2SIRT1HDAC4EP300MEF2D
SCHEMBL14978142 0.84 SIRT2 (0.36) SIRT2SIRT1HDAC4EP300MEF2D
SCHEMBL12692597 0.84 ACE (0.36) SIRT2SIRT1HDAC4EP300MEF2D
SCHEMBL277487 0.83 SIRT2 (0.40) SIRT2SIRT1HDAC4EP300MEF2D
SCHEMBL13311697 0.82 SIRT2 (0.41) SIRT2SIRT1HDAC4EP300MEF2D
SCHEMBL12419152 0.80 FOLH1 (0.33) SIRT2SIRT1HDAC4EP300MEF2D
SCHEMBL14864098 0.79 SIRT2 (0.35) SIRT2SIRT1HDAC4SIRT3ACE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110171166-A1 POLYMER CONJUGATES OF OSTEOCALCIN PEPTIDES NEKTAR THERAPEUTICS 2011-07-14 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110171166-A1 POLYMER CONJUGATES OF OSTEOCALCIN PEPTIDES SOST, PTMS, ALPP SIRT2 2572/4885SIRT1 1581/4885HDAC4 3678/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback